Bankers Trust’s AstraZeneca AZN Stock Holding History

Bankers Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$211K	Sell	2,843 -484	-15%	-$35K	0.13%	123
2014 Q1	$216K	Buy	+3,327	New	+$215K	0.14%	112

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bankers Trust's AZN Position: Q2 2014 in Review

Bankers Trust reduced its AstraZeneca (AZN) stake by 15% in Q2 2014, selling an estimated $35K and leaving 2,843 shares worth $211K. The position accounts for 0.13% of the portfolio, ranked #123.

Bankers Trust first reported a position in AZN in Q1 2014 and has held it in 2 quarters since. The position peaked at $216K in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

Bankers Trust held 2,843 shares of AstraZeneca worth $211K as of Q2 2014.
Bankers Trust sold 484 AstraZeneca shares in Q2 2014, an estimated $35K.
AstraZeneca made up 0.13% of Bankers Trust's portfolio in Q2 2014, its #123 holding.
Bankers Trust first reported a position in AstraZeneca in Q1 2014 and has held it in 2 quarters since.
Bankers Trust's AstraZeneca position peaked at $216K in Q1 2014.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.